(Q36406979)
Statements
Phase 2 study of frontline brentuximab vedotin monotherapy in Hodgkin lymphoma patients aged 60 years and older (English)
Andres Forero-Torres
Jerome Goldschmidt
Robert Chen
Gregg Olsen
Ralph V Boccia
Rodolfo E Bordoni
Jonathan W Friedberg
Jeff P Sharman
Yinghui Wang
Christopher A Yasenchak
16 September 2015
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference